Lack of influence of glutathione S-transferase genotype profile on cancer susceptibility in smokers and nonsmokers

Medical Science Monitor

Volumn 15, Issue 1, 2009, Pages

  Sampaio, Aline Castaldi ^a   Morari, Elaine Cristina ^a   Bufalo, Natassia Elena ^a   Leite, Janaina Luisa ^a   Lima, Carmen Silvia Passos ^a   Ward, Laura S ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Cancer; Cigarette; Diet; Genetic risk; Polymorphisms

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DIET; ETHNICITY; EXERCISE; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEALTH STATUS; HUMAN; LIFE HISTORY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PROSPECTIVE STUDY; SMOKING; SMOKING HABIT;

AGE FACTORS; BRAZIL; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LOGISTIC MODELS; MALE; NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 58649092609     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Varmus H, Pao W, Politi K et al: Oncogenes come of age. Cold Spring Harb Symp Quant Biol, 2005; 70: 1-9
2. Schön D, Bertz J, Görsch B et al: [Federal Cancer Reporting Unit. Surveillance program for cancer registration in Germany] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2004; 47: 429-36
3. Beckman KB, Ames BN: The free radical theory of aging matures. Physiol Rev, 1998; 78: 547-81
4. Van Lieshout EM, Peters WH: Age and gender dependent levels of glutathione and glutathione S-transferases in human lymphocytes. Carcinogenesis, 1998; 19: 1873-75
5. Kiberstis P, Roberts L: It's not just the genes. Science, 2002; 296: 685
6. Taningher M, Malacarne D, Izzotti A et al: Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res, 1999; 436: 227-61
7. Tew KD: Glutathione-associated enzymes in anticancer drug resistance. Cancer Res, 1994; 54: 4313-20
8. Townsend D, Tew K: Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am J Pharmacogenomics, 2003; 3: 157-72
9. Pearson WR: Phylogenies of glutathione transferase families. Methods Enzymol, 2005; 401: 186-204
10. Strange RC, Spiteri MA, Ramachandran S et al: Glutathione-S-transferase family of enzymes. Mutat Res, 2001; 482: 21-26
11. Adler V, Yin Z, Fuchs SY et al: Regulation of JNK signaling by GSTp. EMBO J, 1999; 18: 1321-34
12. Cho SG, Lee YH, Park HS et al: Glutathione S-transferase Mu modulates the stress- activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem, 2001; 276: 12749-55
13. Yin ZM, Liu AH, Jiang Y: Glutathione S-transferase pi protects serum depletion-induced cell death by inhibiting ASK1-MKK7-JNK pathway in the 293 cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 2001; 33: 185-90
14. Zhao X, Fan Y, Shen J et al: Human glutathione S-transferase P1 suppresses MEKK1-mediated apoptosis by regulating MEKK1 kinase activity in HEK293 cells. Mol Cells, 2006; 21: 395-400
15. Morari EC, Leite JL, Granja F et al: The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol. Biomarkers Prev, 2002; 11: 1485-88
16. Morari EC, Lima ABC, Bufalo NE et al: Role of glutathione-S-Transferase and codon 72 of p53 genotypes in epithelial ovarian cancer patients. J Cancer Res Clin Oncol, 2006; 132: 521-28
17. Parl FF: Glutathione S-transferase genotypes and cancer risk. Cancer Lett, 2005; 221: 123-29
18. Zimniak P, Nanduri B, Pikula S et al: Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem, 1994; 224: 893-99
19. Sundberg K, Johansson AS, Stenberg G et al: Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis, 1998; 19: 433-36
20. Yu DS, Hsieh DS, Chang SY: Increasing expression of GST-pi MIF, and ID1 genes in chemoresistant prostate cancer cells. Arch Androl, 2006; 52: 275-81
21. Tremblay S, Pintor Dos Reis P, Bradley G et al: Young patients with oral squamous cell carcinoma: study of the involvement of GSTP1 and deregulation of the Fanconi anemia genes. Arch Otolaryngol Head Neck Surg, 2006; 132: 958-66
22. Granja F, Morari J, Morari EC et al: GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Lett, 2004; 209: 129-37
23. McIlwain CC, Townsend KD, Tew KD: Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene, 2006; 25: 1639-48
24. Nascimento H, Coy CS, Teori MT et al: Possible influence of glutathione S-transferase GSTT1 null genotype on age of onset of sporadic colorectal adenocarcinoma. Dis Colon Rectum, 2003; 46: 510-15
25. Brazilian Institute of Geography and Statistics. Social Indicators pp 1-10. Rio de Janeiro. Available at: http://www.ibge.gov.br/english/ (assessed April 18, 2008)
26. Nutrition country profiles-Brazil, Rome: FAO. Available at: http://www.fao.org/ag/agn/nutrition/bra-e.stm, 2000 (assessed April 18, 2008)
27. Pate RR, Pratt M, Blair SN et al: Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA, 1995; 273: 402-7
28. Lichtenstein P, Holm NV, Verkasalo PK et al: Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 2000; 343: 78-85
29. Gonzalez-Mancha R, Galan JJ, Crespo C et al: Analysis of the ERalpha germline PvuII marker in breast cancer risk. Med Sci Monit, 2008;14(3): 136-43
30. Wu M, Chen S, Wu X: Differences in cytochrome P450 2C19 (CYP2C19) expression in adjacent normal and tumor tissues in Chinese cancer patients. Med Sci Monit, 2006; 12(4): BR174-78
31. Garte S: Metabolic susceptibility genes as cancer risk factors: time for a reassessment? Cancer Epidemiol Biomarkers Prev, 2001; 10: 1233-37
32. Parra FC, Amado RC, Lambertucci JR et al: Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA, 2003; 100: 177-82
33. Rossini A, Rapozo DC, Amorim LM et al: Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res, 2002; 30: 233-40
34. Levy-Costa RB, Sichieri R, Pontes NS et al: Household food availability in Brazil: distribution and trends (1974-2003). Rev Saude Publica, 2005; 39: 530-40
35. Gonzalez CA: Nutrition and cancer: the current epidemiological evidence. Br J Nutr, 2006; 96: 42-45
36. Gonzalez CA: The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr, 2006; 9: 124-26
37. Reszka E, Wasowicz W, Gromadzinska J: Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Br J Nutr, 2006; 96: 609-19
38. Davis CD, Milner JA: Biomarkers for diet and cancer prevention research: potentials and challenges. Acta Pharmacol Sin, 2007; 28: 1262-73
39. Popkin BM: Understanding global nutrition dynamics as a step towards controlling cancer incidence. Nat Rev Cancer, 2007; 7: 61-67
40. Béliveau R, Gingras D: Role of nutrition in preventing cancer. Can Fam Physician, 2007; 53: 1905-11
41. Churg A: Interactions of exogenous or evoked agents and particles: the role of reactive oxygen species. Free Radic Biol Med, 2003; 34: 1230-35
42. Lu CY, Lee HC, Fahn HJ, Wei YH: Oxidative damage elicited by imbalance of free radical scavenging enzymes is associated with large-scale mtDNA deletions in aging human skin. Mutat Res, 1999; 423: 11-21
43. Birch-Machin MA: The role of mitochondria in ageing and carcinogenesis. Clin Exp Dermatol, 2006; 31: 548-52